XML 53 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segments
9 Months Ended
Sep. 27, 2014
Business Segments  
Note 9. Business Segmentation

Since the year ended December 28, 2013, the Company has generated significant revenue from its ingredients operations and has made operational changes, including changes in the organizational structure to support the ingredients operations.  As a result, on December 29, 2013, the Company began segregating its financial results for ingredients operations, and has following three reportable segments.

 

Core standards, and contract services segment includes supply of phytochemical reference standards, which are small quantities of plant-based compounds typically used to research an array of potential attributes, reference materials, and related contract services.

 

Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients to the manufacturers of consumer products in various industries including the nutritional supplement, food and beverage and animal health industries.

 

Scientific and regulatory consulting segment which consist of providing scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage potential health and regulatory risks.

  

The “Other” classification includes corporate items not allocated by the Company to each reportable segment. Further, there are no intersegment sales that require elimination.  The Company evaluates performance and allocates resources based on reviewing gross margin by reportable segment.

 

    Core Standards           Scientific and              
    and Contract           Regulatory              
Three months ended September 27, 2014  

Services

segment

   

Ingredients

segment

    Consulting segment     Other     Total  
Net sales   $ 1,814,622     $ 2,031,250     $ 293,838     $ -     $ 4,139,710  
Cost of sales     1,239,356       1,200,790       176,618       -       2,616,764  
                                         
Gross profit     575,266       830,460       117,220       -       1,522,946  
                                         
Operating expenses:                                        
Sales and marketing     259,951       243,068       15,643       -       518,662  
General and administrative     -       -       -       1,651,718       1,651,718  
Operating expenses     259,951       243,068       15,643       1,651,718       2,170,380  
                                         
Operating income (loss)   $ 315,315     $ 587,392     $ 101,577     $ (1,651,718 )   $ (647,434 )

 

    Core Standards           Scientific and              
    and Contract           Regulatory              
Three months ended September 28, 2013  

Services

segment

   

Ingredients

segment

    Consulting segment     Other     Total  
Net sales   $ 1,574,970     $ 780,489     $ 362,749     $ -     $ 2,718,207  
Cost of sales     1,309,562       484,511       173,947       -       1,968,020  
                                         
Gross profit     265,408       295,977       188,802       -       750,187  
                                         
Operating expenses:                                        
Sales and marketing     328,043       165,025       12,000       -       505,068  
General and administrative     -       -       -       1,453,611       1,453,611  
Loss from investment in affiliate     -       -       -       33,281       33,281  
Operating expenses     328,043       165,025       12,000       1,486,892       1,991,960  
                                         
Operating income (loss)   $ (62,635 )   $ 130,952     $ 176,802     $ (1,486,892 )   $ (1,241,773 )

 

    Core Standards                          
    and Contract           Regulatory              
Nine months ended September 27, 2014   Services segment    

Ingredients

segment

    Consulting segment     Other     Total  
Net sales   $ 5,407,455     $ 4,889,431     $ 773,116     $ -     $ 11,070,002  
Cost of sales     3,728,521       2,962,505       472,256       -       7,163,282  
                                         
Gross profit     1,678,934       1,926,926       300,860       -       3,906,720  
                                         
Operating expenses:                                        
Sales and marketing     694,523       793,414       66,840       -       1,554,777  
General and administrative     -       -       -       6,458,027       6,458,027  
Loss from investment in affiliate     -       -       -       21,543       21,543  
Operating expenses     694,523       793,414       66,840       6,479,570       8,034,347  
                                         
Operating income (loss)   $ 984,411     $ 1,133,512     $ 234,020     $ (6,479,570 )   $ (4,127,627 )

  

    Core Standards           Scientific and              
    and Contract           Regulatory              
Nine months ended September 28, 2013   Services segment    

Ingredients

segment

    Consulting segment     Other     Total  
Net sales   $ 4,978,727     $ 2,032,616     $ 808,610     $ (60,285 )   $ 7,759,668  
Cost of sales     3,661,772       1,260,697       452,479       955       5,375,903  
                                         
Gross profit (loss)     1,316,955       771,919       356,131       (61,240 )     2,383,765  
                                         
Operating expenses:                                        
Sales and marketing     1,120,897       599,395       14,600       131,159       1,866,051  
General and administrative     -       -       -       4,155,792       4,155,792  
Loss from investment in affiliate     -       -       -       33,281       33,281  
Operating expenses     1,120,897       599,395       14,600       4,320,232       6,055,124  
                                         
Operating income (loss)   $ 196,058     $ 172,524     $ 341,531     $ (4,381,472 )   $ (3,671,359 )

 

    Core Standards and     Scientific and              
    Contract Services     Ingredients    

Regulatory

Consulting

             
At September 27, 2014   segment     segment     segment     Other     Total  
Total assets   $ 3,394,033     $ 2,618,062     $ 277,007     $ 2,410,049     $ 8,699,151  
                                         

 

    Core Standards and     Scientific and              
    Contract Services     Ingredients    

Regulatory

Consulting

             
At December 28, 2013   segment     segment     segment     Other     Total  
Total assets   $ 2,952,270     $ 1,083,856     $ 139,765     $ 4,811,001     $ 8,986,892